{
    "SPADE_UN_27638": {
        "Sequence Information": {
            "Peptide Name": "Retrocyclin-1, RC-100",
            "Sequence": "GICRCICGRGICRCICGR",
            "Sequence Length": 18,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiviral",
                "Anticancer"
            ],
            "Binding Target": "1. Membrane Protein\n2. Lipid Bilayer\n3. Virus entry\n4. gp120",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.",
                    "Pubmed ID": "11854483",
                    "Reference": "Proc Natl Acad Sci U S A. 2002;99:1813-1818",
                    "Author": "Cole AM, Hong T, Boo LM, Nguyen T, Zhao C, Bristol G, Zack JA, Waring AJ, Yang OO, Lehrer RI",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/11854483"
                },
                {
                    "Title": "A theta-defensin composed exclusively of D-amino acids is active against HIV-1.",
                    "Pubmed ID": "15175019",
                    "Reference": "J Pept Res. 2004;63:469-476",
                    "Author": "Owen SM, Rudolph D, Wang W, Cole AM, Sherman MA, Waring AJ, Lehrer RI, Lal RB",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15175019"
                },
                {
                    "Title": "Activity of alpha- and theta-defensins against primary isolates of HIV-1.",
                    "Pubmed ID": "15210812",
                    "Reference": "J Immunol. 2004;173:515-520",
                    "Author": "Wang W, Owen SM, Rudolph D, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15210812"
                },
                {
                    "Title": "Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.",
                    "Pubmed ID": "16790431",
                    "Reference": "J Biol Chem. 2006;281:32755-32764",
                    "Author": "Wang W, Mulakala C, Ward SC, Jung G, Luong H, Pham D, Waring AJ, Kaznessis Y, Lu W, Bradley KA, Lehrer RI",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/16790431"
                }
            ],
            "Mass": 1942.45,
            "PI": 9.01,
            "Net Charge": 4,
            "Hydrophobicity": 0.74,
            "Frequent Amino Acids": "CGI",
            "Absent Amino Acids": "ADEFHKLMNOPQSTUVWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 8,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_27638",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03436",
                    "Similarity": 1.0,
                    "Sequence": "RCICGRGICRCICGRGIC"
                },
                {
                    "SPADE_ID": "SPADE_UN_09523",
                    "Similarity": 1.0,
                    "Sequence": "RCICGRGIC"
                },
                {
                    "SPADE_ID": "SPADE_UN_27638",
                    "Similarity": 1.0,
                    "Sequence": "GICRCICGRGICRCICGR"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Pseudomonas aeruginosa(MIC=<3µg/ml),Pseudomonas aeruginosa(MIC=>50µg/ml),Escherichia coli(MIC=<3µg/ml),Escherichia coli(MIC=<3µg/ml),Listeria monocytogenes(MIC=<3µg/ml),Listeria monocytogenes(MIC=<3µg/ml),Staphylococcus aureus(MIC=<3µg/ml),Staphylococcus aureus(MIC=>50µg/ml),HIV-1B 92US076(IC50 I=1.93µg/ml),HIV-1B 93US151(IC50 I=1.69µg/ml),HIV-1B 92HT593(IC50 I=5.73µg/ml),HIV-1B 92US727(IC50 I=6.46µg/ml),HIV-1B 92US657(IC50 I=4.96µg/ml),HIV-1B 92US714(IC50 I=>10µg/ml),HIV-1A 193317(IC50 I=>10µg/ml),HIV-1A 196554(IC50 I=5.73µg/ml),HIV-1A 92RW026(IC50 I=6.28µg/ml),HIV-1C 192431(IC50 I=5.18µg/ml),HIV-1C 193358(IC50 I=>10µg/ml),HIV-1C 93MW959(IC50 I=6.41µg/ml),HIV-1D 93UG053(IC50 I=6.38µg/ml),HIV-1D 92UG005(IC50 I=5.18µg/ml),HIV-1D 94UG114(IC50 I=3.69µg/ml),HIV-1 CRF01-AE CMU08(IC50 I=7.77µg/ml),HIV-1 CRF01-AE CMU10(IC50 I=4.79µg/ml),HIV-1 CRF01-AE HM14(IC50 I=3.09µg/ml),HIV-1 CRF01-AE HM13(IC50 I=5.16µg/ml),HIV-1 CRF01-AE HM16(IC50 I=2.28µg/ml),HIV-1 CRF01-AE 92TH001(IC50 I=6.85µg/ml),HIV-1 CRF01-AE 93TH060(IC50 I=7.39µg/ml),HIV-1G RU132(IC50 I=5.27µg/ml),HIV-1G RU570(IC50 I=8.63µg/ml),HIV-1A(IC50 E=5.51±1.13µg/ml),HIV-1B(IC50 E=4.15±0.99µg/ml),HIV-1C(IC50 E=>10µg/ml),HIV-1 CRF01-AE(IC50 E=5.33±0.80µg/ml),HIV-1D(IC50 E=4.57±0.53µg/ml),HIV-1G(IC50 E=5.86±0.95µg/ml),HIV-1BF(IC50 E=7.24µg/ml),Human adenocarcinoma TZM-bl(no activity data),Bacillus anthracis Sterne 7702(MEC=0.89±0.03µg/ml),Bacillus anthracis Sterne 7702(MEC=0.69±0.05µg/ml)"
        }
    }
}